Lowe BA - Search Results

1

Association of codon 72 polymorphism of p53 with lower prostate cancer risk.

Henner WD, Evans AJ, Hough KM, Harris EL, Lowe BA, Beer TM. Henner WD, et al. Among authors: lowe ba. Prostate. 2001 Dec 1;49(4):263-6. doi: 10.1002/pros.10021. Prostate. 2001. PMID: 11746272

2

Polymorphisms of GSTP1 and related genes and prostate cancer risk.

Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, Henner WD. Beer TM, et al. Among authors: lowe ba. Prostate Cancer Prostatic Dis. 2002;5(1):22-7. doi: 10.1038/sj.pcan.4500549. Prostate Cancer Prostatic Dis. 2002. PMID: 15195126

3

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.

Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Beer TM, et al. Among authors: lowe ba. J Clin Oncol. 2003 Jan 1;21(1):123-8. doi: 10.1200/jco.2003.05.117. J Clin Oncol. 2003. PMID: 12506180 Clinical Trial.

4

High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.

Beer TM, Lemmon D, Lowe BA, Henner WD. Beer TM, et al. Among authors: lowe ba. Cancer. 2003 Mar 1;97(5):1217-24. doi: 10.1002/cncr.11179. Cancer. 2003. PMID: 12599228 Free article.

5

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer.

Beer TM, Hough KM, Garzotto M, Lowe BA, Henner WD. Beer TM, et al. Among authors: lowe ba. Semin Oncol. 2001 Aug;28(4 Suppl 15):49-55. doi: 10.1016/s0093-7754(01)90155-1. Semin Oncol. 2001. PMID: 11685729 Clinical Trial.

6

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer.

Beer TM, Pierce WC, Lowe BA, Henner WD. Beer TM, et al. Among authors: lowe ba. Ann Oncol. 2001 Sep;12(9):1273-9. doi: 10.1023/a:1012258723075. Ann Oncol. 2001. PMID: 11697840 Free article. Clinical Trial.

7

Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer.

Beer TM, Garzotto M, Lowe BA, Ellis WJ, Montalto MA, Lange PH, Higano CS. Beer TM, et al. Among authors: lowe ba. Clin Cancer Res. 2004 Feb 15;10(4):1306-11. doi: 10.1158/1078-0432.ccr-1021-03. Clin Cancer Res. 2004. PMID: 14977829 Clinical Trial.

8

Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy.

Beer TM, Myrthue A, Garzotto M, O'hara MF, Chin R, Lowe BA, Montalto MA, Corless CL, Henner WD. Beer TM, et al. Among authors: lowe ba. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2225-32. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598784 Clinical Trial.

9

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.

Ackerman DA, Barry JM, Wicklund RA, Olson N, Lowe BA. Ackerman DA, et al. Among authors: lowe ba. J Urol. 1993 Dec;150(6):1845-50. doi: 10.1016/s0022-5347(17)35912-8. J Urol. 1993. PMID: 7693981

10

The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate: a comparative evaluation.

Lowe BA, Barry JM. Lowe BA, et al. J Urol. 1990 Jun;143(6):1142-5. doi: 10.1016/s0022-5347(17)40209-6. J Urol. 1990. PMID: 2342175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters